0001437749-21-013629.txt : 20210528
0001437749-21-013629.hdr.sgml : 20210528
20210528083205
ACCESSION NUMBER: 0001437749-21-013629
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aubrey de Lavenu Harold Andre
CENTRAL INDEX KEY: 0001737899
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21976293
MAIL ADDRESS:
STREET 1: APT 627 VALE DO LOBO
CITY: ALMANCIL
STATE: S1
ZIP: 8135-034
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2018-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001737899
Aubrey de Lavenu Harold Andre
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
Convertible note
1.60
2018-11-15
4
J
0
171632
1.60
D
2016-11-25
Common Stock
107270
548980
D
On November 15, 2018, $171,632 of a $200,000 convertible promissory note issued by the issuer on November 25, 2016 to the reporting person was repaid by the issuer to the reporting person thereby reducing the amount due under the note to $28,368 and accordingly reducing the number of common stock shares of the issuer issuable upon conversion of the promissory note from 125,000 shares of common stock by 107,270 shares of common stock to 17,730 shares of common stock.
The convertible note matured on November 25, 2018, however, the ability to convert the note into shares did not expire on such maturity date.
At December 31, 2018, the reporting person also held 33,321 shares of the issuer's common stock directly, and held convertible promissory notes convertible into 548,980 shares of the issuer's common stock.
The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021.
/s/ Harold Aubrey de Lavenu
2021-05-28